AAAAAA

   
Results: 1-13 |
Results: 13
THE EFFECT OF PLASMA DRUG CONCENTRATIONS ON HIV-1 CLEARANCE RATE DURING QUADRUPLE DRUG-THERAPY
Authors: HOETELMANS RMW REIJERS MHE WEVERLING GJ TENKATE RW WIT FWNM MULDER JW WEIGEL HM FRISSEN PHJ ROOS M JURRIAANS S SCHUITEMAKER H DEWOLF F BEIJNEN JH LANGE JMA
Citation: Rmw. Hoetelmans et al., THE EFFECT OF PLASMA DRUG CONCENTRATIONS ON HIV-1 CLEARANCE RATE DURING QUADRUPLE DRUG-THERAPY, AIDS, 12(11), 1998, pp. 111-115
MAINTENANCE THERAPY AFTER QUADRUPLE INDUCTION THERAPY IN HIV-1-INFECTED INDIVIDUALS - AMSTERDAM DURATION OF ANTIRETROVIRAL MEDICATION (ADAM) STUDY
Authors: REIJERS MHE WEVERLING GJ JURRIAANS S WIT FWNM WEIGEL HM TENKATE RW MULDER JW FRISSEN PHJ VANLEEUWEN R REISS P SCHUITEMAKER H DEWOLF F LANGE JMA
Citation: Mhe. Reijers et al., MAINTENANCE THERAPY AFTER QUADRUPLE INDUCTION THERAPY IN HIV-1-INFECTED INDIVIDUALS - AMSTERDAM DURATION OF ANTIRETROVIRAL MEDICATION (ADAM) STUDY, Lancet, 352(9123), 1998, pp. 185-190
PROSPECTIVE LONGITUDINAL ANALYSIS OF VIRAL LOAD AND SURROGATE MARKERSIN RELATION TO CLINICAL PROGRESSION IN HIV TYPE 1-INFECTED PERSONS
Authors: BRUISTEN SM FRISSEN PHJ VANSWIETEN P HARRIGAN PR KINGHORN I LARDER B WEIGEL HM DEVRIES E REGEZ RM HENRICHS JH KOOT M HUISMAN JG
Citation: Sm. Bruisten et al., PROSPECTIVE LONGITUDINAL ANALYSIS OF VIRAL LOAD AND SURROGATE MARKERSIN RELATION TO CLINICAL PROGRESSION IN HIV TYPE 1-INFECTED PERSONS, AIDS research and human retroviruses, 13(4), 1997, pp. 327-335
ASPERGILLOMA FORMATION IN A PNEUMATOCELE ASSOCIATED WITH PNEUMOCYSTIS-CARINII PNEUMONIA
Authors: SCHOUWINK JH WEIGEL HM BLAAUWGEERS JLG SCHREURS AJM
Citation: Jh. Schouwink et al., ASPERGILLOMA FORMATION IN A PNEUMATOCELE ASSOCIATED WITH PNEUMOCYSTIS-CARINII PNEUMONIA, AIDS, 11(1), 1997, pp. 135-137
COTRIMOXAZOLE IS EFFECTIVE AS PRIMARY PROPHYLAXIS FOR TOXOPLASMIC ENCEPHALITIS IN HIV-INFECTED PATIENTS - A CASE-CONTROL STUDY
Authors: WEIGEL HM DEVRIES E REGEZ RM HENRICHS JH TENVELDEN JJAM FRISSEN PHJ VANDERMEER JTM
Citation: Hm. Weigel et al., COTRIMOXAZOLE IS EFFECTIVE AS PRIMARY PROPHYLAXIS FOR TOXOPLASMIC ENCEPHALITIS IN HIV-INFECTED PATIENTS - A CASE-CONTROL STUDY, Scandinavian journal of infectious diseases, 29(5), 1997, pp. 499-502
HIGH-DOSE NEVIRAPINE IN PREVIOUSLY UNTREATED HUMAN-IMMUNODEFICIENCY-VIRUS TYPE 1-INFECTED PERSONS DOES NOT RESULT IN SUSTAINED SUPPRESSION OF VIRAL REPLICATION
Authors: DEJONG MD VELLA S CARR A BOUCHER CAB IMRIE A FRENCH M HOY J SORICE S PAULUZZI S CHIODO F WEVERLING GJ VANDERENDE ME FRISSEN PJ WEIGEL HM KAUFFMANN RH LANGE JMA YOON R MORONI M HOENDERDOS E LEITZ G COOPER DA HALL D REISS P
Citation: Md. Dejong et al., HIGH-DOSE NEVIRAPINE IN PREVIOUSLY UNTREATED HUMAN-IMMUNODEFICIENCY-VIRUS TYPE 1-INFECTED PERSONS DOES NOT RESULT IN SUSTAINED SUPPRESSION OF VIRAL REPLICATION, The Journal of infectious diseases, 175(4), 1997, pp. 966-970
COMPLICATIONS OF VARICELLA-ZOSTER VIRUS REACTIVATION IN HIV-INFECTED HOMOSEXUAL MEN
Authors: VEENSTRA J VANPRAAG RME KROL A VANDILLEN PMEW WEIGEL HM SCHELLEKENS PTA LANGE JMA COUTINHO RA VANDERMEER JTM
Citation: J. Veenstra et al., COMPLICATIONS OF VARICELLA-ZOSTER VIRUS REACTIVATION IN HIV-INFECTED HOMOSEXUAL MEN, AIDS, 10(4), 1996, pp. 393-399
ZIDOVUDINE PLUS INTERFERON-ALPHA VERSUS ZIDOVUDINE ALONE IN HIV-INFECTED SYMPTOMATIC OR ASYMPTOMATIC PERSONS WITH CD4-THAN-150X10(6)( CELL COUNTS GREATER)I - RESULTS OF THE ZIDON TRIAL/
Authors: FERNANDEZCRUZ E LANG JM FRISSEN J FURNER V CHATEAUVERT M BOUCHER CAB DOWD P STEVENS J GOLD J MICHELMORE H BENSON E SPELMAN E HOY J WRIGHT E FRENCH M HUDSON J MALLAL S BODSWORTH N STINGL G MAYERHOFER S KRONAWETTER M TSOUKAS C SZABO T KATLAMA C GUERMONPREZ G RAFFI F BILLAUD E MILPIED B BOURGEOT V FLEISHMANN M BARRIER JH DELZANT G WINTER C MEHARZI J TREPO C COTTE L ROUGIER P HASSAIRI N CHOUTET P BESNIER JM LAFEUILLADE A RASOKAT H GROSS G MAUSCH HE STRATIGOS J POLYDOROV D STAVRIANEAS N KIOSSES V MANDALAKI T KARAFOULIDOU A KARABINIS A STERGIOU G PLOUMIDES G PITSAS A TASSOPOULOS N KOUTSOUNOPOULOS G HATZAKIS A MORONI M DARMINIO A BINI T CHIODO F COLANGELI V RICCHI E AIUTI F FERRARA R MEZZAROMA I LANGE JMA FRISSEN PHJ SPRENGER HG KROON FP VANDERENDE ME DEMARIE S KOOPMANS PP DOLMANS WMV SCHREIJ GS WEIGEL HM TENNAPEL CHH TENKATE RW MARANON G ZABAY JM COSIN J PENA JM RUBIO R RIBERA E VAZQUEZ JMM LEAL M ANDREU J CARTON JA ASENSI V GOMEZTRUJILLO F ORIHUELA F SERRANO C FERRER E MANDAL BK JOHNSON M MCKARTHY K FARMER D TANG A MITCHELL SA BROWN J TOORAWA R YEO J
Citation: E. Fernandezcruz et al., ZIDOVUDINE PLUS INTERFERON-ALPHA VERSUS ZIDOVUDINE ALONE IN HIV-INFECTED SYMPTOMATIC OR ASYMPTOMATIC PERSONS WITH CD4-THAN-150X10(6)( CELL COUNTS GREATER)I - RESULTS OF THE ZIDON TRIAL/, AIDS, 9(9), 1995, pp. 1025-1035
EFFICACY AND TOXICITY OF 2 DOSES OF TRIMETHOPRIM-SULFAMETHOXAZOLE AS PRIMARY PROPHYLAXIS AGAINST PNEUMOCYSTIS-CARINII PNEUMONIA IN PATIENTSWITH HUMAN-IMMUNODEFICIENCY-VIRUS
Authors: SCHNEIDER MME NIELSEN TL NELSING S HOEPELMAN AIM SCHATTENKERK JKME VANDERGRAAF Y KOLSTERS AFP BORLEFFS JCC DANNER SA VANLEEUWEN R FRISSEN JPHJ WEIGEL HM VANDERENDE IME SPRENGER HG KAUFFMANN RH KROON F MEENHORST PL TENNAPEL CHH SCHREIJ G TENKATE RW JUTTMANN JR KOOPMANS PP
Citation: Mme. Schneider et al., EFFICACY AND TOXICITY OF 2 DOSES OF TRIMETHOPRIM-SULFAMETHOXAZOLE AS PRIMARY PROPHYLAXIS AGAINST PNEUMOCYSTIS-CARINII PNEUMONIA IN PATIENTSWITH HUMAN-IMMUNODEFICIENCY-VIRUS, The Journal of infectious diseases, 171(6), 1995, pp. 1632-1636
DISSEMINATED PENICILLIUM-MARNEFFEI INFECTION AS AN IMPORTED DISEASE IN HIV-1-INFECTED PATIENTS - DESCRIPTION OF 2 CASES AND A REVIEW OF THELITERATURE
Authors: KOK I VEENSTRA J RIETRA PJGM DIRKSGO S BLAAUWGEERS JLG WEIGEL HM
Citation: I. Kok et al., DISSEMINATED PENICILLIUM-MARNEFFEI INFECTION AS AN IMPORTED DISEASE IN HIV-1-INFECTED PATIENTS - DESCRIPTION OF 2 CASES AND A REVIEW OF THELITERATURE, Netherlands journal of medicine, 44(1), 1994, pp. 18-22
ALTERNATING NEVIRAPINE AND ZIDOVUDINE TREATMENT OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE 1-INFECTED PERSONS DOES NOT PROLONG NEVIRAPINE ACTIVITY
Authors: DEJONG MD LOEWENTHAL M BOUCHER CAB VANDERENDE I HALL D SCHIPPER P IMRIE A WEIGEL HM KAUFFMANN RH KOSTER R SEVILLE P ROCKLIN R COOPER DA LANGE JMA
Citation: Md. Dejong et al., ALTERNATING NEVIRAPINE AND ZIDOVUDINE TREATMENT OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE 1-INFECTED PERSONS DOES NOT PROLONG NEVIRAPINE ACTIVITY, The Journal of infectious diseases, 169(6), 1994, pp. 1346-1350
ZIDOVUDINE AND INTERFERON-ALPHA, COMBINATION THERAPY VERSUS ZIDOVUDINE MONOTHERAPY IN SUBJECTS WITH SYMPTOMATIC HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION
Authors: FRISSEN PHJ VANDERENDE ME TENNAPEL CHH WEIGEL HM SCHREIJ GS KAUFFMANN RH KOOPMANS PP HOEPELMAN AIM DEBOER JB WEVERLING GJ HAVERKAMP G DOWD P MIEDEMA F SCHUURMAN R BOUCHER CAB LANGE JMA
Citation: Phj. Frissen et al., ZIDOVUDINE AND INTERFERON-ALPHA, COMBINATION THERAPY VERSUS ZIDOVUDINE MONOTHERAPY IN SUBJECTS WITH SYMPTOMATIC HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION, The Journal of infectious diseases, 169(6), 1994, pp. 1351-1355
THE CONCORDE TRIAL
Authors: DANNER SA SCHATTENKERK JKME LOELIGER AE VANDERMEER JTM REISS P HENRICHS JM FRISSEN PHJ WEIGEL HM MULDER JW MEENHORST PL VANDERWOLF MGB TENVEEN JH CLAESSEN FAP VEENSTRA J BORLEFFS JCC HOEPELMAN IM SCHNEIDER ME DEMARIE S VANDERENDE ME VOETS W KAUFFMANN RH KROON FP JUTTMAN JR FOLMER SCCR FERWERDA J TENKATE RW VANLEUSEN R VREDEN SGS PERENBOOM R SPRENGER HG TENNAPEL CHH
Citation: Sa. Danner et al., THE CONCORDE TRIAL, Lancet, 341(8855), 1993, pp. 1276-1276
Risultati: 1-13 |